The global contrast media agents market is expected to reach US$ 6,860.6 Mn in 2027 from US$ 4,855.2 Mn in 2018. The contrast media agents market is estimated to grow with a CAGR of 4.0% from 2019-2027. The market is driven by the factors such as, increasing prevalence of chronic diseases, development in diagnostic imaging modalities coupled with rising numbers of diagnostic test procedures and increasing numbers of approvals for contrast agents. However, the factors such as side effects associated with contrast media agents and stringent regulations for radio imaging agents are expected to restrain the growth of market. In an aging society where chronic diseases is a leading factor in the health system, technical advancements are necessary to preserve the quality of life through keeping the affordable prices. Chronic diseases can be defined as medical conditions that lasts for one year or more and requires ongoing medical attention or limit activities of daily living. Chronic diseases such as cancer, heart diseases, musculoskeletal diseases, and others are the leading causes of death and disability that requires several imaging modalities for diagnostic and treatment monitoring purposes. According to the National Center for Chronic Disease Prevention and Health Promotion, chronic diseases takes up US$3.3 trillion in annual health care costs. The rising prevalence of musculoskeletal diseases are the major factors of the market growth.For instance, according to Arthritis Foundation, in 2017, approximately 54 million adults have been diagnosed with arthritis.
Almost 300,000 babies and children have arthritis or a rheumatic condition.The common type of arthritis is osteoarthritis, which affects approximately 31 million Americans.
By the end of 2040, number of people expected to have doctor-diagnosed arthritis will be above 78 million. Global contrast media agents market was segmented by type, imaging modality, indication and route of administration.The type segment was classified as iodinated contrast media, gadolinium based contrast media, barium-based contrast media, microbubble contrast media.
Based on the imaging modality the market is classified as X-Ray/CT, magnetic resonance imaging and ultrasound.On the basis of indication the market is classified as cardiovascular disorders, cancer, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, nephrological disorders.
And based on the route of administration the market is divided into intravascular, oral and rectal. Some of the major primary and secondary sources included in the report for the contrast media agents market are World Health Organization, Dubai Health Authority, Canadian Cancer Society, Canadian Agency for Drugs and Technologies in Health, American Cancer Society, CBI Ministry of Foreign Affairs, Cancer Organization Soutien, Global Burden of Diseases, Entabeni Pretoria, South Africa and others.
Our reports have been used by over 10K customers, including:
513 pages •
By Global Industry Analysts
• Apr 2021
- The global market for Contrast Media is projected to reach US$5.3 billion by 2025, driven by the growing number of imaging procedures such as X-Rays, MRI, CT, and Ultrasound supported by the prevalence of chronic diseases among the growing global population and the ensuing diagnostic burden and demand for imaging...
The global interventional radiology products market is projected to reach USD 14.1 billion by 2026 from USD 10.2 billion in 2021, at a CAGR of 6.6% during the forecast period. The growth in this market can be attributed to the rising prevalence of chronic diseases, growing geriatric population, increasing demand for minimally invasive procedures,...
The global intraoperative imaging market size is projected to reach USD 2.5 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 5.2%. Factors such as the technological advancements in the market are propelling the growth of the intraoperative imaging market. Additionally, rising cases of surgeries, investments from both private and...
The global optical imaging market is projected to reach USD 3.3 billion by 2026 from USD 1.6 billion in 2021, at a CAGR of 14.8%.during the forecast period. Factors such as the rising aging population, increasing research & development activities in the life sciences sector, and increasing applications of optical imaging techniques in drug...
Executive Summary Global Medical Imaging Market was valued at USD 39.94 Billion in the year 2020. Medical Imaging refers to use of different imaging modalities to get visual representations of interior of a body for diagnostic and therapeutic purposes. The medical imaging field has advanced at a great pace, with technological...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Medical Imaging Software Market Report
The global medical imaging software market by revenue is expected to grow at a CAGR of over 7% during the period 2020–2026.
Advances in imaging systems and analysis software that help reduce exposure...
The North America nuclear medicine market was valued at USD 5,624 million in 2020 and is projected to be worth USD 10,273 million by 2026 registering a CAGR of 10.4%, over the forecast period 2021-2026. Several general principles have been implemented by government organizations with key goals to reduce disease transmission, preserve...
277 pages •
By The Business Research Company
• Jun 2021
Microbiology Diagnostic Devices And Equipment Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global microbiology diagnostic devices and equipment market as it emerges from the COVID -19 shut down. Description: Where...
The global medical composites market size is projected to grow from USD 922 million in 2020 to USD 1,478 million by 2025, at a CAGR of 9.9% between 2020 and 2025. Medical composites are demanded in various applications such as diagnostic imaging, composite body implants, surgical instruments, dental, and others; due to their advantages properties...
The Near Infrared Imaging Market was valued at US$ million 395.14 in 2019 and is projected to reach US$ 543.24 million by 2027; it is expected to grow at a CAGR of 4.2% from 2020 to 2027. The growth of the Near Infrared Imaging market is mainly attributed to factors such as rising number of surgical procedures worldwide, and advantages...
Research And Development
Surgical Procedures Performed
Chronic Disease Prevalence
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.